- Home
- RPRX vs EVRG Comparison
RPRX vs EVRG Comparison
Compare RPRX & EVRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RPRX
- EVRG
- Stock Information
- Founded
- RPRX 1996
- EVRG 2017
- Country
- RPRX United States
- EVRG United States
- Employees
- RPRX N/A
- EVRG N/A
- Industry
- RPRX Biotechnology: Pharmaceutical Preparations
- EVRG Power Generation
- Sector
- RPRX Health Care
- EVRG Utilities
- Exchange
- RPRX Nasdaq
- EVRG Nasdaq
- Market Cap
- RPRX 16.2B
- EVRG 17.9B
- IPO Year
- RPRX 2020
- EVRG N/A
- Fundamental
- Price
- RPRX $40.42
- EVRG $76.77
- Analyst Decision
- RPRX Strong Buy
- EVRG Strong Buy
- Analyst Count
- RPRX 3
- EVRG 10
- Target Price
- RPRX $46.00
- EVRG $77.35
- AVG Volume (30 Days)
- RPRX 2.8M
- EVRG 2.1M
- Earning Date
- RPRX 11-05-2025
- EVRG 11-06-2025
- Dividend Yield
- RPRX 2.18%
- EVRG 3.48%
- EPS Growth
- RPRX N/A
- EVRG 13.62
- EPS
- RPRX 1.77
- EVRG 3.64
- Revenue
- RPRX $2,349,553,000.00
- EVRG $5,880,300,000.00
- Revenue This Year
- RPRX $36.16
- EVRG $5.19
- Revenue Next Year
- RPRX $2.04
- EVRG $3.76
- P/E Ratio
- RPRX $22.85
- EVRG $21.12
- Revenue Growth
- RPRX 3.69
- EVRG 4.34
- 52 Week Low
- RPRX $24.05
- EVRG $59.33
- 52 Week High
- RPRX $41.00
- EVRG $79.32
- Technical
- Relative Strength Index (RSI)
- RPRX 74.39
- EVRG 49.50
- Support Level
- RPRX $35.92
- EVRG $76.00
- Resistance Level
- RPRX $37.40
- EVRG $77.61
- Average True Range (ATR)
- RPRX 1.09
- EVRG 1.01
- MACD
- RPRX 0.26
- EVRG -0.35
- Stochastic Oscillator
- RPRX 91.94
- EVRG 24.76
About RPRX Royalty Pharma plc
Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.
About EVRG Evergy Inc.
Evergy is a regulated electric utility serving eastern Kansas and western Missouri. Major operating subsidiaries include Evergy Metro, Evergy Kansas Central, Evergy Missouri West, and Evergy Transmission Co. The utility has a combined rate base of approximately $20 billion, about half in Kansas and the rest split between Missouri and federal jurisdiction. Evergy is one of the largest wind energy suppliers in the US.